US lawmakers Mylan, Teva promotes the proofing of drug pricing: a statement

14

PHOTO FILE: Teva Pharmaceutical Industry Logo in Tel Aviv, Israel 19 February, 2019. REUTERS / Amir Cohen

WASHINGTON (Reuters) – One of the US panel's representative panel on Wednesday asked three drug makers to turn documents on them as part of their ongoing peer review of generic drug price increases and put "the efforts". appears to be stone walls "put the companies.

Elijah Cummings, Chairman of the House of Commons, accompanied by Senator S. Bernie Sanders, the stepped member of the Seanad Budget Committee, sent the letters to Mylan NV, Teva Pharmaceutical Industries Ltd and Heritage Pharmaceuticals held in private, said the legislators in a statement.

Reporting by Susan Heavey; edited by Jason Neely

Our Standards:The principles of Thomson Reuters Trust.

(TTTranslate tags) USA (t) USA (t) HEALTH CARE (t) PRICE (t) America (t) Israel (t) Company News (t) Health / Medicine (t) Government / Politics (t) General News (t) United States House of Representatives (t) Europe (t) Middle East (t) US Government News (t) Pharmaceuticals and Medical Research (TRBC) (t) United States Drug Development and Device (t) Regulation

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.